Cargando…
Acute respiratory distress syndrome and severe acute respiratory syndrome: circulating interleukin 4 level could be a marker
Autores principales: | Guery, B., Georges, H., Labalette, M., Leroy, O., d'Escrivan, T., Gonin, X., Mouton, Y., Dessaint, J.P., Yazdanpanah, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Éditions scientifiques et médicales Elsevier SAS.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127567/ https://www.ncbi.nlm.nih.gov/pubmed/15679239 http://dx.doi.org/10.1016/j.medmal.2004.04.008 |
Ejemplares similares
-
Syndrome respiratoire aigu sévère
por: Guery, B, et al.
Publicado: (2003) -
Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit
por: Boussekey, N., et al.
Publicado: (2005) -
Pneumonie virale sévère de l'immunocompétent
por: Guery, B, et al.
Publicado: (2004) -
Interleukin-22 mitigates acute respiratory distress syndrome (ARDS)
por: Taghavi, Sharven, et al.
Publicado: (2021) -
Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
por: Koumbourlis, Anastassios C., et al.
Publicado: (2020)